Goldman-backed Starling states no options to go after EU financial institution license, enlargement to come from computer software

Goldman-backed Starling states no options to go after EU financial institution license, enlargement to come from computer software


Important Points
  • Digital lender Starling will not re-apply for a European Union banking license and will as a substitute go after intercontinental enlargement through its software program enterprise Motor, incoming CEO claimed.
  • Engine is a software platform that Starling sells to other providers, so that they can established up their personal electronic banks.
  • Raman Bhatia outlined the company’s worldwide growth ideas, in his to start with general public remarks since his March appointment as Starling CEO in March.



Resource

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
Finance

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infringement case against Hims, and the companies agreed that Hims would sell Novo’s Ozempic and Wegovy […]

Read More
Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’
Finance

Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’

Key Points Raymond James estimates that what consumers pay in higher gas prices could total exactly what they’re set to gain with the tax changes under President Donald Trump’s “big beautiful bill.” The stimulus was expected to boost both the U.S. economy and markets in 2026.  While consumers may not get as much of a […]

Read More
Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more
Finance

Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more

Check out the companies making headlines before the bell: Kohl’s — Shares tumbled 9% after the retailer posted disappointing fourth-quarter revenue of $4.97 billion, below the LSEG consensus of $5.03 billion. On the other hand, fourth quarter earnings of $1.07 per share exceeded the expected 85 cents per share. Casey’s General Stores — The convenience […]

Read More